CVE-2026-120327: The click tracking middleware accepts an arbitrary target URL and redirects to it
Source GCVE Database
Not known to be exploited · CVSS 5.3 Medium : upgrade to 4.2.0 or 3.12.5 when convenient.
Data as of 3 Nov 2026, 13:30 UTC
Thin evidence
One scorer or none| CNA (TYPO3) | CVSS 4.0 | 5.3 |
|---|
- Patch
- Available – fixed in 4.2.0, 3.12.5
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:P/VC:N/VI:N/VA:N/SC:N/SI:L/SA:NExploitation evidence
Disclosed: evidence found.
CVE published 3 Nov 2026
Detectable: no evidence on record.
No public nuclei template indexed
Weaponized: no evidence on record.
No public exploit code indexed in Metasploit or Exploit-DB
Exploited in the wildExploited: no evidence on record.
Not in CISA KEV and no source reports exploitation
Observed by OffSeq MirageSeen by Mirage: no evidence on record.
No attack traffic recorded by OffSeq Mirage sensors
A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 3 Nov 2026.
What to do
Upgrade Extension "Mail" and mediaessenz/mail to 4.2.0 or 3.12.5.
Affected software
| Product | Affected | Fixed in |
|---|---|---|
| Extension "Mail"mediaessenz/mail | Affected
| Fixed in
|
| Extension "Mail"mediaessenz/mail | Affected
| Fixed in
|
Packagistmediaessenz/mailpkg:composer/mediaessenz/mailOther threats | Affected
| Fixed in
|
Check your own hosts for these packages with threat-finder (opens in a new tab), our free open-source scanner.
AI-suggested
If you cannot patch yet, avoid using or sharing links that leverage the vulnerable click tracking middleware for redirection. Implementing URL validation or restricting redirects to trusted domains can mitigate the risk.
Description
This vulnerability involves a click tracking middleware that accepts an arbitrary target URL and redirects users to it. This behavior can be exploited by attackers to redirect users from the legitimate website to external, potentially malicious sites. The issue is classified under CWE-601 (Open Redirect).